Sign up for our daily briefing

Make your busy days simpler with the Axios AM and PM newsletters. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to the Axios Closer newsletter for insights into the day’s business news and trends and why they matter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with the Axios Sports newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with the Axios Des Moines newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with the Axios Tampa Bay newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Aïda Amer/Axios

Global health leaders around the world are sharpening their goals of eliminating tuberculosis within this generation, but at the same time they are facing the threat of the U.S. — the biggest contributor to the fight — cutting back its support.

Why it matters: Today is World Tuberculosis Day. Most cases of tuberculosis (TB) can be treated and cured, yet the disease continues to infect 10 million and kill 1.6 million people a year — more than any other infectious disease. And if the U.S. cuts its funding for international programs, despite having the tools to get rid of it, it's likely to stay the course.

Background: President Trump's proposed budget for fiscal year 2020 includes major slashes to global health spending, including...

  • A 29% reduction in FY20 for the Global Fund, an international nonprofit that fights AIDS, Malaria and TB. There's also a $1 billion cut to the 3-year commitment by the U.S. to the Global Fund in the next "replenishment period."
  • A 22% drop in funds to PEPFAR, the President's Emergency Plan For AIDS Relief, which is a government initiative to fight the global AIDS epidemic.
  • Of note: Congress appropriates funding for the budget and it's not expected to agree to these particular reductions, but the proposal shows the administration's current priorities.

In response, multiple organizations, including PATH, sent letters asking Congress to reject the proposed reductions.

The Center for Strategic and International Studies invited Axios to its private roundtable discussing the launch of a report last week by the Lancet Commission that gave a roadmap to eradicate TB in less than 30 years — which it said could be done if funding is increased to pave the way for better diagnostics, treatments and public awareness programs.

  • The roundtable included several members of the commission, including the UN special envoy on tuberculosis.

Details:

  • Nick Herbert, U.K. member of Parliament, says, "Words are not enough." He notes the importance of the commission's recommendation of accountability mechanisms like independent observations in report cards to evaluate efforts of individual countries or NGOs.
  • Irene Koek, deputy assistant administrator in the USAID Global Health Bureau, agrees with the commission that countries need to acknowledge a shared responsibility to fund TB programs. To help countries meet this goal, the agency has developed a global accelerator, which is a new business model to empower local entities to generate performance-based measurement systems to tackle TB.
  • Mark Dybul, of Georgetown University Medical Center, praises the commitments voiced by African Union leaders and says their example could set a pattern for Asia to follow. China and India in particular need to increase their domestic funding to tackle the disease, he adds, suggesting a cigarette tax could be one mechanism.

In honor of World Tuberculosis Day, multiple public health agencies have issued statements over the past week.

  • The World Health Organization issued recommendations that included new guidance to help address the threat of drug-resistant TB.
  • The Centers for Disease Control and Prevention published in its MMWR Weekly preliminary 2018 surveillance data showing the U.S. has the lowest number of TB cases ever reported, but is also demonstrating a slowing in progress. "At the current rate of progress, TB will not be eliminated in the U.S. this century."
  • The European Centre for Disease Prevention and Control said that in order to reach the target, "new intersectoral approaches are required, current tools need to be used more effectively and a people-centred approach to care is paramount."

The big picture: Stephen Morrison, SVP and director of CSIS Health Policy Center, tells Axios...

"The picture is mixed and uncertain."
"On the positive side: Across the leadership ranks at NIH, USAID, CDC, HHS, DOD, NSC, there is rising awareness of TB as the largest infectious disease killer, the source of dangerous resistant forms, the need to accelerate R&D of vaccines, diagnostics, therapies."
"Our cooperation with South Africa and India on TB [is] pretty solid and robust. Health cooperation with China has quietly endured despite the proliferating strains. With Russia not much ground for cooperation left. Our mounting strategic confrontation with China and Russia suggests diminishing will and space into the future for cooperation on TB."
"Our real influence is however limited to PEPFAR, USAID TB account, the Global Fund, and the NIH R&D account. Trump's proposed budget cuts suggest [there's no] serious commitment to protect the major accounts."

Meanwhile, research continues for a better vaccine and new drug treatments, including a novel treatment that the FDA is reviewing, as well as those using precision medicine for antibiotic-resistant strains. PLOS Medicine is releasing a special collection of novel TB treatment studies now and over the next several weeks.

Go deeper: WHO report: TB remains "public health crisis" despite decline

Go deeper

Updated 30 mins ago - Technology

Mayors see cryptocurrency as a way to address income inequality

Illustration: Sarah Grillo/Axios

At the U.S. Conference of Mayors' meeting in D.C. this week, there's buzz around the idea of giving cryptocurrency accounts to low-income people.

Why it matters: Cities have been experimenting with newfangled ways to address income inequality — like guaranteed income programs — and the latest wave of trials could involve paying benefits or dividends in bitcoin, stablecoin or other digital currencies.

Updated 32 mins ago - Politics & Policy

Omicron dashboard

Illustration: Aïda Amer/Axios

  1. Health: FDA OKs antiviral drug remdesivir for non-hospitalized COVID patients — Walensky: CDC language "pivoting" on "fully vaccinated" — Fauci: "Confident" Omicron cases will peak in February
  2. Vaccines: Team USA 100% vaccinated against COVID ahead of Beijing Olympics — Kids' COVID vaccination rates are particularly low in rural America — Annual COVID vaccine preferable to boosters, says Pfizer CEO.
  3. Politics: Arizona governor sues Biden administration over COVID funds tied to mandates — Biden concedes U.S. should have done more testing — Arizona says it "will not be intimidated" on anti-mask school policies.
  4. World: Greece imposes vaccine mandate for people 60 and older — Austria approves COVID vaccine mandate for adults — Beijing officials urge COVID-19 "emergency mode" before Winter Olympics.
  5. Variant tracker
Updated 3 hours ago - Sports

Experts predict major boom for North American sports stadiums

Rendering of the $375 million Moody Center on the UT-Austin campus. Photo courtesy of Moody Center

Stadium and arena construction in North America will total a relatively tame $5.8 billion this year, a 12% decrease from 2021.

The big picture: What the industry lacks in construction it expects to make up for in design, with experts predicting a sports venue boom over the next half-decade, SBJ reports.